A surge in heart procedures and higher demand for cold and flu medicines helped Johnson & Johnson report solid gains in revenue and profit for the second quarter
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law.
For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.Knee replacements and other elective surgeries are also picking upJ&J’s quarterly earnings are regarded as a bellwether for healthcare because the company has large pharmaceutical, medical-device and consumer-health divisions.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Johnson & Johnson beats on earnings, hikes full-year guidance as medtech sales surgeThe results come amid investor anxiety over the thousands of lawsuits claiming that J&J's talc-based baby powder and other products caused cancer.
Read more »
Johnson & Johnson sues Biden administration over Medicare drug price negotiationsMerck, Bristol Myers Squibb, the U.S. Chamber of Commerce and PhRMA filed separate lawsuits against the provision last month.
Read more »
Johnson & Johnson joins Merck, others, in fighting Medicare drug-price programJohnson & Johnson has joined companies such as Merck & Co. Inc. Bristol Myers Squibb Co. and other entities in suing the federal government over Medicare’s...
Read more »
Johnson & Johnson must pay $18.8 million to California cancer patient in baby powder suit | CNN BusinessJohnson & Johnson must pay $18.8 million to a California man who said he developed cancer from exposure to its baby powder, a jury decided on Tuesday, a setback for the company as it seeks to settle thousands of similar cases over its talc-based products in US bankruptcy court.
Read more »
Johnson & Johnson must pay $18.8 million to California cancer patient in baby powder suitJohnson & Johnson must pay $18.8 million to a California man who said he developed cancer from exposure to its baby powder, a jury decided on Tuesday, a setback for the company as it seeks to settle thousands of similar cases over its talc-based products in US bankruptcy court.
Read more »
Millions could soon have access to life-saving tuberculosis drug following online uproarA treatment for multi-drug resistant tuberculosis could soon become more accessible for millions of people worldwide.
Read more »